ArticleScience translational medicine2011

Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.

Nathan G Dolloff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.